| Lastest Insider Transactions Of HALOZYME THERAPEUTICS, INC. ( HALO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-08-17 | Sell | 60,000 | 104.59 | 6,275,592 | 2026-08-19 20:01:15 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-08-17 | Option Exercise | 60,000 | 18.41 | 1,104,600 | 2026-08-19 20:01:15 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2026-08-10 | Sell | 1,626 | 102.80 | 167,153 | 2026-08-11 17:43:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-07-08 | Sell | 1,923 | 79.77 | 153,391 | 2026-07-09 17:19:34 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-07-08 | Option Exercise | 1,923 | 12.07 | 23,211 | 2026-07-09 17:19:34 |
| HALO | HALOZYME THERAPEUTICS, INC. | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | 2026-06-30 | Option Exercise | 10,000 | 0.00 | 0 | 2026-07-02 16:45:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2026-07-01 | Sell | 1,625 | 76.71 | 124,651 | 2026-07-02 16:42:08 |
| HALO | HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh | Directior | 2026-06-29 | Sell | 7,304 | 75.00 | 547,800 | 2026-06-30 17:25:10 |
| HALO | HALOZYME THERAPEUTICS, INC. | Krishnan Mahesh | Directior | 2026-06-29 | Option Exercise | 7,304 | 38.46 | 280,912 | 2026-06-30 17:25:10 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2026-06-12 | Option Exercise | 5,034 | 0.00 | 0 | 2026-06-15 16:09:46 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-06-01 | Sell | 50,000 | 67.40 | 3,370,008 | 2026-06-03 20:06:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-06-01 | Option Exercise | 50,000 | 12.07 | 603,500 | 2026-06-03 20:06:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2026-06-01 | Sell | 1,625 | 66.21 | 107,591 | 2026-06-02 17:20:34 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-05-11 | Sell | 50,000 | 68.68 | 3,433,875 | 2026-05-13 17:50:19 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-05-11 | Option Exercise | 50,000 | 12.07 | 603,500 | 2026-05-13 17:50:19 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2026-05-01 | Sell | 1,625 | 63.48 | 103,155 | 2026-05-05 17:05:10 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-04-06 | Sell | 10,000 | 63.50 | 634,982 | 2026-04-07 17:13:42 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-04-06 | Option Exercise | 10,000 | 12.07 | 120,700 | 2026-04-07 17:13:42 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-04-01 | Sell | 40,000 | 64.81 | 2,592,237 | 2026-04-02 18:28:38 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-04-01 | Option Exercise | 40,000 | 12.07 | 482,800 | 2026-04-02 18:28:38 |
| HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | 2026-03-09 | Sell | 28,857 | 67.75 | 1,955,160 | 2026-03-10 19:18:55 |
| HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | 2026-03-09 | Option Exercise | 21,546 | 33.51 | 722,006 | 2026-03-10 19:18:55 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-03-02 | Sell | 50,000 | 69.52 | 3,476,157 | 2026-03-04 18:56:16 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-03-02 | Option Exercise | 50,000 | 12.07 | 603,500 | 2026-03-04 18:56:16 |
| HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | 2026-02-20 | Option Exercise | 2,666 | 0.00 | 0 | 2026-02-24 18:19:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2026-02-20 | Option Exercise | 12,343 | 0.00 | 0 | 2026-02-24 18:16:08 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2026-02-20 | Option Exercise | 12,020 | 0.00 | 0 | 2026-02-24 18:14:46 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-02-20 | Option Exercise | 39,193 | 0.00 | 0 | 2026-02-24 18:12:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2026-02-16 | Option Exercise | 16,812 | 0.00 | 0 | 2026-02-17 18:53:47 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2026-02-16 | Option Exercise | 23,773 | 0.00 | 0 | 2026-02-17 18:52:46 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-02-16 | Option Exercise | 89,055 | 0.00 | 0 | 2026-02-17 18:51:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-02-03 | Sell | 50,000 | 77.07 | 3,853,503 | 2026-02-05 19:38:43 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2026-02-03 | Option Exercise | 50,000 | 12.07 | 603,500 | 2026-02-05 19:38:43 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2026-01-05 | Sell | 2,000 | 70.25 | 140,500 | 2026-01-06 18:55:55 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2026-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2026-01-06 18:55:28 |
| HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | 2025-11-01 | Sell | 4,263 | 65.19 | 277,905 | 2025-12-19 17:39:43 |
| HALO | HALOZYME THERAPEUTICS, INC. | Caudill Cortney | SVP, CHIEF OPERATING OFFICER | 2025-11-01 | Option Exercise | 9,326 | 0.00 | 0 | 2025-12-19 17:39:43 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2025-12-01 | Sell | 829 | 71.60 | 59,356 | 2025-12-01 19:50:47 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2025-12-01 | Sell | 829 | 71.60 | 59,356 | 2025-12-01 19:50:47 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-11-26 | Sell | 16,569 | 68.92 | 1,141,925 | 2025-12-01 19:31:44 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-11-26 | Option Exercise | 16,569 | 8.11 | 134,375 | 2025-12-01 19:31:44 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-11-10 | Sell | 60,000 | 69.47 | 4,167,930 | 2025-11-12 18:54:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-11-10 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-11-12 18:54:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2025-11-10 | Sell | 2,000 | 68.48 | 136,960 | 2025-11-12 17:58:21 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-10-01 | Sell | 60,000 | 71.86 | 4,311,745 | 2025-10-03 18:00:05 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-10-01 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-10-03 18:00:05 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2025-10-01 | Sell | 2,000 | 75.24 | 150,481 | 2025-10-01 18:29:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-22 | Sell | 2,227 | 77.95 | 173,584 | 2025-09-23 16:15:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-22 | Sell | 2,227 | 77.95 | 173,584 | 2025-09-23 16:15:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-22 | Sell | 2,227 | 77.95 | 173,584 | 2025-09-23 16:15:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-22 | Sell | 2,227 | 77.95 | 173,584 | 2025-09-23 16:15:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-10 | Sell | 20,000 | 75.71 | 1,514,267 | 2025-09-11 17:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-09-10 | Option Exercise | 12,406 | 12.11 | 150,217 | 2025-09-11 17:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-09-02 | Sell | 60,000 | 74.08 | 4,444,627 | 2025-09-04 17:41:27 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-09-02 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-09-04 17:41:27 |
| HALO | HALOZYME THERAPEUTICS, INC. | Connaughton Bernadette | Directior | 2025-09-02 | Sell | 4,000 | 73.68 | 294,736 | 2025-09-02 20:11:41 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-08-11 | Sell | 60,000 | 63.62 | 3,817,389 | 2025-08-13 18:22:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-08-11 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-08-13 18:22:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-07-08 | Sell | 60,000 | 56.46 | 3,387,518 | 2025-07-10 19:43:30 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-07-08 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-07-10 19:43:30 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-06-20 | Sell | 60,000 | 53.09 | 3,185,280 | 2025-06-24 17:40:12 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-06-20 | Option Exercise | 60,000 | 8.11 | 486,600 | 2025-06-24 17:40:12 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2025-06-12 | Option Exercise | 5,035 | 0.00 | 0 | 2025-06-13 17:33:05 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-04-28 | Sell | 4,497 | 60.37 | 271,467 | 2025-04-28 18:04:19 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-04-01 | Sell | 503 | 64.05 | 32,217 | 2025-04-01 18:32:16 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-03-03 | Sell | 5,000 | 58.69 | 293,458 | 2025-03-03 20:46:27 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-03-03 | Sell | 5,000 | 58.69 | 293,458 | 2025-03-03 20:46:27 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2025-02-25 | Sell | 21,697 | 58.10 | 1,260,681 | 2025-02-27 18:32:38 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2025-02-23 | Option Exercise | 4,747 | 0.00 | 0 | 2025-02-24 17:11:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2025-02-23 | Option Exercise | 7,012 | 0.00 | 0 | 2025-02-24 17:07:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-02-23 | Option Exercise | 6,688 | 0.00 | 0 | 2025-02-24 17:04:21 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-02-23 | Option Exercise | 22,436 | 0.00 | 0 | 2025-02-24 17:01:43 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2025-02-15 | Option Exercise | 34,652 | 0.00 | 0 | 2025-02-18 18:42:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2025-02-16 | Option Exercise | 22,205 | 0.00 | 0 | 2025-02-18 18:41:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2025-02-15 | Option Exercise | 29,085 | 0.00 | 0 | 2025-02-18 18:39:13 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2025-02-15 | Option Exercise | 122,786 | 0.00 | 0 | 2025-02-18 18:37:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-02-03 | Sell | 5,000 | 56.30 | 281,517 | 2025-02-04 18:07:32 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2025-01-06 | Sell | 10,000 | 50.01 | 500,060 | 2025-01-07 16:14:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, CHIEF LEGAL OFFICER | 2025-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2025-01-06 17:12:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-10-15 | Sell | 20,000 | 53.50 | 1,070,059 | 2024-10-16 18:53:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-10-15 | Option Exercise | 20,000 | 19.06 | 381,255 | 2024-10-16 18:53:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-10-08 | Sell | 20,000 | 53.29 | 1,065,743 | 2024-10-09 17:39:44 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-10-08 | Option Exercise | 20,000 | 13.87 | 277,400 | 2024-10-09 17:39:44 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-09-24 | Sell | 30,000 | 56.88 | 1,706,440 | 2024-09-26 18:06:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-09-24 | Option Exercise | 30,000 | 13.87 | 416,100 | 2024-09-26 18:06:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-09-17 | Sell | 20,000 | 62.45 | 1,249,096 | 2024-09-18 18:49:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-09-17 | Option Exercise | 20,000 | 16.65 | 333,000 | 2024-09-18 18:49:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-09-10 | Sell | 30,000 | 59.13 | 1,773,790 | 2024-09-12 17:56:59 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-09-10 | Option Exercise | 30,000 | 13.87 | 416,100 | 2024-09-12 17:56:59 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Sell | 20,000 | 61.40 | 1,228,020 | 2024-08-21 18:03:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Option Exercise | 20,000 | 16.65 | 333,000 | 2024-08-21 18:03:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Sell | 20,000 | 61.40 | 1,228,020 | 2024-08-21 18:03:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-08-20 | Option Exercise | 20,000 | 16.65 | 333,000 | 2024-08-21 18:03:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-08-13 | Sell | 30,000 | 57.15 | 1,714,451 | 2024-08-15 16:59:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-08-13 | Option Exercise | 30,000 | 13.87 | 416,100 | 2024-08-15 16:59:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Directior | 2024-08-12 | Sell | 29,881 | 56.53 | 1,689,294 | 2024-08-14 16:57:27 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-07-23 | Sell | 20,000 | 55.00 | 1,100,023 | 2024-07-24 17:48:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-07-23 | Option Exercise | 20,000 | 11.65 | 232,954 | 2024-07-24 17:48:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-07-22 | Sell | 5,000 | 53.93 | 269,662 | 2024-07-23 16:37:10 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-07-22 | Option Exercise | 5,000 | 22.50 | 112,500 | 2024-07-23 16:37:10 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-06-26 | Sell | 30,000 | 51.93 | 1,557,940 | 2024-06-28 16:06:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-06-26 | Option Exercise | 30,000 | 22.50 | 675,000 | 2024-06-28 16:06:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-06-18 | Sell | 10,000 | 49.43 | 494,260 | 2024-06-20 16:17:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-06-18 | Option Exercise | 10,000 | 8.11 | 81,100 | 2024-06-20 16:17:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Directior | 2024-06-11 | Sell | 20,000 | 50.31 | 1,006,300 | 2024-06-13 16:15:42 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-05-21 | Sell | 20,000 | 45.27 | 905,480 | 2024-05-22 17:24:16 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-05-21 | Option Exercise | 20,000 | 8.11 | 162,200 | 2024-05-22 17:24:16 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-04-16 | Sell | 20,000 | 38.42 | 768,390 | 2024-04-17 19:22:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-04-16 | Option Exercise | 20,000 | 8.11 | 162,200 | 2024-04-17 19:22:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-26 | Option Exercise | 11,618 | 11.20 | 130,160 | 2024-03-26 19:38:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-12 | Sell | 20,000 | 41.95 | 839,100 | 2024-03-13 17:22:18 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-12 | Option Exercise | 20,000 | 11.37 | 227,338 | 2024-03-13 17:22:18 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-27 | Sell | 20,000 | 39.75 | 794,923 | 2024-02-28 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-27 | Option Exercise | 7,471 | 8.11 | 60,590 | 2024-02-28 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-16 | Option Exercise | 10,376 | 0.00 | 0 | 2024-02-20 18:59:00 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2024-02-16 | Option Exercise | 4,796 | 0.00 | 0 | 2024-02-20 18:55:59 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-16 | Option Exercise | 10,422 | 0.00 | 0 | 2024-02-20 18:53:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-16 | Option Exercise | 37,884 | 0.00 | 0 | 2024-02-20 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-15 | Option Exercise | 3,386 | 0.00 | 0 | 2024-02-16 17:47:15 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-15 | Option Exercise | 1,254 | 0.00 | 0 | 2024-02-16 17:41:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-15 | Option Exercise | 13,092 | 0.00 | 0 | 2024-02-16 17:39:34 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-10 | Option Exercise | 8,133 | 0.00 | 0 | 2024-02-13 16:18:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-10 | Option Exercise | 2,502 | 0.00 | 0 | 2024-02-13 16:15:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-10 | Option Exercise | 31,281 | 0.00 | 0 | 2024-02-13 16:12:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-01-16 | Sell | 20,000 | 36.00 | 720,000 | 2024-01-18 16:07:33 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-01-16 | Option Exercise | 20,000 | 12.07 | 241,400 | 2024-01-18 16:07:33 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2024-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2024-01-05 16:04:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-12-12 | Sell | 20,000 | 40.01 | 800,262 | 2023-12-13 19:48:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-12-12 | Option Exercise | 20,000 | 12.81 | 256,247 | 2023-12-13 19:48:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-11-14 | Sell | 20,000 | 39.43 | 788,670 | 2023-11-16 16:18:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-11-14 | Option Exercise | 20,000 | 14.06 | 281,273 | 2023-11-16 16:18:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-10-17 | Sell | 10,000 | 36.52 | 365,200 | 2023-10-17 19:28:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-10-17 | Option Exercise | 10,000 | 19.98 | 199,800 | 2023-10-17 19:28:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-09-19 | Sell | 10,000 | 39.10 | 390,980 | 2023-09-19 16:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-09-19 | Option Exercise | 10,000 | 19.98 | 199,800 | 2023-09-19 16:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-29 | Sell | 30,000 | 42.69 | 1,280,730 | 2023-08-31 17:35:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-29 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-08-31 17:35:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-08-22 | Sell | 10,000 | 42.41 | 424,070 | 2023-08-23 17:08:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-08-22 | Option Exercise | 10,000 | 19.68 | 196,778 | 2023-08-23 17:08:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-15 | Sell | 30,000 | 43.49 | 1,304,820 | 2023-08-17 17:29:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-15 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-08-17 17:29:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Directior | 2023-08-11 | Sell | 20,000 | 43.73 | 874,520 | 2023-08-15 16:04:28 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-07-25 | Sell | 30,000 | 43.09 | 1,292,750 | 2023-07-27 16:03:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-07-25 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-07-27 16:03:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-07-18 | Sell | 10,000 | 40.43 | 404,300 | 2023-07-19 16:10:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-07-18 | Option Exercise | 20,000 | 15.30 | 306,098 | 2023-07-19 16:10:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-06-21 | Sell | 10,000 | 36.00 | 360,000 | 2023-06-22 18:20:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-06-21 | Option Exercise | 10,000 | 18.41 | 184,100 | 2023-06-22 18:20:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-04-18 | Sell | 10,000 | 36.00 | 360,000 | 2023-04-19 18:07:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-04-18 | Option Exercise | 10,000 | 18.41 | 184,100 | 2023-04-19 18:07:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Sell | 2,984 | 49.55 | 147,854 | 2023-04-19 18:01:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Option Exercise | 2,984 | 18.41 | 54,935 | 2023-04-19 18:01:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-03-07 | Sell | 30,000 | 43.82 | 1,314,550 | 2023-03-09 17:04:25 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-03-07 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-03-09 17:04:25 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2023-02-28 | Sell | 20,000 | 48.11 | 962,200 | 2023-03-01 18:07:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Sell | 10,000 | 49.55 | 495,483 | 2023-02-28 16:59:40 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-16 | Sell | 2,878 | 49.26 | 141,770 | 2023-02-21 19:05:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-16 | Option Exercise | 6,112 | 0.00 | 0 | 2023-02-21 19:05:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-16 | Sell | 2,525 | 49.26 | 124,382 | 2023-02-21 19:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-16 | Option Exercise | 5,094 | 0.00 | 0 | 2023-02-21 19:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-16 | Sell | 11,061 | 49.26 | 544,865 | 2023-02-21 18:59:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-16 | Option Exercise | 21,010 | 0.00 | 0 | 2023-02-21 18:59:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-15 | Sell | 10,000 | 48.39 | 483,940 | 2023-02-17 06:29:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-15 | Option Exercise | 3,386 | 0.00 | 0 | 2023-02-17 06:29:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-15 | Option Exercise | 1,254 | 0.00 | 0 | 2023-02-17 06:25:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-15 | Option Exercise | 13,092 | 0.00 | 0 | 2023-02-17 06:20:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-10 | Option Exercise | 16,016 | 0.00 | 0 | 2023-02-14 17:24:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-10 | Option Exercise | 3,892 | 0.00 | 0 | 2023-02-14 17:21:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-10 | Option Exercise | 64,075 | 0.00 | 0 | 2023-02-14 17:17:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-07 | Sell | 30,000 | 51.01 | 1,530,150 | 2023-02-09 17:44:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-07 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-02-09 17:44:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-01-17 | Sell | 30,000 | 51.30 | 1,539,149 | 2023-01-19 17:07:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-01-17 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-01-19 17:07:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-01-17 | Sell | 10,000 | 50.46 | 504,590 | 2023-01-18 19:07:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2023-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2023-01-04 18:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2022-12-13 | Sell | 30,000 | 58.11 | 1,743,302 | 2022-12-15 19:12:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2022-12-13 | Option Exercise | 30,000 | 14.66 | 439,800 | 2022-12-15 19:12:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2022-12-13 | Sell | 10,000 | 58.67 | 586,675 | 2022-12-13 18:09:50 |
